Abstract
The effect of nonsteroid anti-inflammatory drugs (NSAIDs) after acute myocardial infarction was studied in a retrospective study of 88 patients who were receiving regular NSAID treatment at randomization in the Danish Verapamil Infarction Trial II. There were no significant differences in mortality or major events between NSAID-treated patients versus controls (1,687); however, in a multivariate analysis a nonsignificant beneficial trend in favor of NSAIDs was observed.
Publication types
-
Clinical Trial
-
Comparative Study
-
Randomized Controlled Trial
MeSH terms
-
Aged
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
-
Calcium Channel Blockers / therapeutic use
-
Drug Therapy, Combination
-
Female
-
Follow-Up Studies
-
Humans
-
Male
-
Middle Aged
-
Myocardial Infarction / drug therapy*
-
Myocardial Infarction / mortality
-
Prognosis
-
Prospective Studies
-
Safety
-
Secondary Prevention
-
Survival Rate
-
Verapamil / therapeutic use
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Calcium Channel Blockers
-
Verapamil